All Pharma News
Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific ADC

Biocytogen Enters Collaboration with ABL Bio to Develop New Bispecific ADC
BUSINESSWIRE
25 Mar 2024
Share Share
Biocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement

Biocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement
BUSINESSWIRE
20 Feb 2024
Share Share
Biocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement

Biocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement
BUSINESSWIRE
19 Feb 2024
Share Share
Biocytogen Launches RenBiologics

Biocytogen Launches RenBiologics
BUSINESSWIRE
23 Jan 2024
Share Share
Biocytogen Enters into Bispecific ADC Agreement with Radiance

Biocytogen Enters into Bispecific ADC Agreement with Radiance
BUSINESSWIRE
08 Jan 2024
Share Share
Biocytogen & CtM Achieve Milestone Progress in Developing a TCR-mimic Antibody

Biocytogen & CtM Achieve Milestone Progress in Developing a TCR-mimic Antibody
BUSINESSWIRE
27 Dec 2023
Share Share
Biocytogen Enters into Multi-Target Antibody Agreement with Neurocrine Bio

Biocytogen Enters into Multi-Target Antibody Agreement with Neurocrine Bio
BUSINESSWIRE
19 Dec 2023
Share Share
Biocytogen Enters into Antibody Agreement with Ona Therapeutics

Biocytogen Enters into Antibody Agreement with Ona Therapeutics
BUSINESSWIRE
18 Dec 2023
Share Share
Biocytogen Announces 16 Poster Presentations and Booth Exhibition at SITC 2023

Biocytogen Announces 16 Poster Presentations and Booth Exhibition at SITC 2023
BUSINESSWIRE
24 Oct 2023
Share Share
Biocytogen/Eucure Biopharma to Present Complete Clinical Data from YH003

Biocytogen/Eucure Biopharma to Present Complete Clinical Data from YH003
BUSINESSWIRE
17 Oct 2023
Share Share